| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/06/1997 | CA2200696A1 Viral vectors and line for gene therapy |
| 02/05/1997 | EP0757106A2 Nucleic acid-bondable magnetic carrier and method for isolating nucleic acid using the same |
| 02/05/1997 | EP0757102A1 Genetic transformation using a PARP inhibitor |
| 02/05/1997 | EP0757101A2 Circular plasmids from Rhodococcus |
| 02/05/1997 | EP0757100A1 Over-expression and purification of a truncated thermostable DNA polymerase by protein fusion |
| 02/05/1997 | EP0757099A2 CTLA4 mutant molecules and uses thereof |
| 02/05/1997 | EP0756708A1 Use of human neutrophil lipocalin (hnl) as a diagnostic marker and anti-hnl-antibody preparation |
| 02/05/1997 | EP0756639A1 Nucleic acids and methods for the discrimination between syncytium inducing and non syncytium inducing variants of the human immunodeficiency virus |
| 02/05/1997 | EP0756638A1 Method and means for detecting and treating disorders in the blood coagulation cascade |
| 02/05/1997 | EP0756636A1 Chondroitinases i and ii, methods of preparation, and use thereof |
| 02/05/1997 | EP0756634A1 An in vivo gene expression system |
| 02/05/1997 | EP0756632A1 Plant gene specifying acetyl coenzyme a carboxylase and transformed plants containing same |
| 02/05/1997 | EP0756631A1 Method of eliminating genetic routes for bacteriophage evolution and products produced thereby |
| 02/05/1997 | EP0756630A1 Recombinant pgp3, methods of preparation and use in diagnosis and therapy |
| 02/05/1997 | EP0756629A1 Pharmaceutical formulations for treating japanese cedar pollen allergy |
| 02/05/1997 | EP0756628A1 Morphogenic protein-specific cell surface receptors and uses therefor |
| 02/05/1997 | EP0756627A1 Hek5, hek7, hek8, hek11, new eph-like receptor protein tyrosine kinases |
| 02/05/1997 | EP0756626A1 Human gamma 3 gaba-a receptor subunit and stably co-transfected cell lines |
| 02/05/1997 | EP0756604A1 Melanoma antigens |
| 02/05/1997 | EP0756601A1 Compositions and methods for cell transformation |
| 02/05/1997 | EP0756490A1 Human bone stimulating factor |
| 02/05/1997 | EP0756488A1 Tumor suppressor gene and methods for detection of cancer, monitoring of tumor progression and cancer treatment |
| 02/05/1997 | EP0652895A4 Compounds which inhibit hiv replication. |
| 02/05/1997 | EP0616642B1 New thrombin-inhibiting proteins from terrestrial leeches |
| 02/05/1997 | EP0463144B1 Magnetically responsive fluorescent polymer particles and application thereof |
| 02/05/1997 | CN1142247A Extracorporeal ceel culture and transplantation kits |
| 02/05/1997 | CN1142189A Platelet-special chimeric immunoglobulin and methods of use thereof |
| 02/05/1997 | CN1142188A 人生长激素 Human Growth Hormone |
| 02/05/1997 | CN1142187A Paramunity inducer based on combinations of poxvirus components, process to prepare it and its use as medicament |
| 02/05/1997 | CN1141953A Formation of plasmid-type herpes-virus carrier for specific expression of human nerve cell and usage of same |
| 02/05/1997 | CN1141952A Carotenoid production by fermentation |
| 02/04/1997 | US5599921 Oligonucleotide families useful for producing primers |
| 02/04/1997 | US5599917 Inhibition of interferon-γ with oligonucleotides |
| 02/04/1997 | US5599907 Production and use of multimeric hemoglobins |
| 02/04/1997 | US5599906 Hybrid regulatory proteins capable of binding to a specific region of dna that controls expression of indicator genes |
| 02/04/1997 | US5599905 Interleukin-4 receptors |
| 02/04/1997 | US5599904 Encoded by dna carried on plsmid; glucocorticoid/mineralocorticoid/thyroid hormone/retinoic acid and estrogen related receptors |
| 02/04/1997 | US5599797 Oligonucleotides having phosphorothioate linkages of high chiral purity |
| 02/04/1997 | US5599796 Treatment of urogenital cancer with boron neutron capture therapy |
| 02/04/1997 | US5599788 Wound healing agents; dermal fibroplast adhesion promoter |
| 02/04/1997 | US5599709 Recombinant DNA encoding neuronal α-bungarotoxin-binding proteins |
| 02/04/1997 | US5599708 Stimulate formation of osteoclast bone cells; treatment of bone marrow disorders |
| 02/04/1997 | US5599707 Human prohibitin DNA |
| 02/04/1997 | US5599706 Ribozymes targeted to apo(a) mRNA |
| 02/04/1997 | US5599704 Monitoring the development or maintenance of breast cancer; anticarcinogenic and -tumor agents |
| 02/04/1997 | US5599701 Inositol-excreting yeast |
| 02/04/1997 | US5599693 Culture product |
| 02/04/1997 | US5599692 Antigenic polypeptides of Taenia ovis |
| 02/04/1997 | US5599691 Herpes simplex virus as a vector |
| 02/04/1997 | US5599689 Process for making 1,3-propanediol from carbohydrates using mixed microbial cultures |
| 02/04/1997 | US5599675 DNA sequencing by stepwise ligation and cleavage |
| 02/04/1997 | US5599672 Polymerase amplification |
| 02/04/1997 | US5599671 Human A2B adenosine receptor assay |
| 02/04/1997 | US5599670 β-glucuronidase and glucuronide permease gene system |
| 02/04/1997 | US5599669 Cytokine-induced marker for inflammatory response |
| 02/04/1997 | US5599662 Oliconucleotide primers and probes for the detection of HIV-1 |
| 02/04/1997 | US5599544 Recombinant infectious bovine rhinotracheitis virus |
| 02/04/1997 | US5599542 Diagnosis, treatment and vaccine for malaria; induction of antibodies that attack plasmodium in the schizont stage |
| 02/04/1997 | US5599537 Salmonella virulence genes |
| 02/04/1997 | US5599504 Apparatus for detecting denaturation of nucleic acid |
| 02/04/1997 | CA1338891C Recombinant dna methods, vectors and host cells |
| 01/30/1997 | WO1997003348A1 Self-contained device integrating nucleic acid extraction, amplification and detection |
| 01/30/1997 | WO1997003345A2 Detection and quantification of human herpesvirus 7 by enzymic amplification dna virus dna |
| 01/30/1997 | WO1997003211A1 Antisense inhibition of hepatitis b virus replication |
| 01/30/1997 | WO1997003210A1 Glycosylase mediated detection of nucleotide sequences at candidate loci |
| 01/30/1997 | WO1997003208A1 Riboflavin-production process by means of micro-organisms with modified isocitratlyase activity |
| 01/30/1997 | WO1997003205A2 Novel dna sequences and their use for identifying defence-inducing agents in plants |
| 01/30/1997 | WO1997003204A2 (s)-hydroxynitrillyase from hevea brasiliensis |
| 01/30/1997 | WO1997003203A2 Generation of immune responses to prostate-specific antigen (psa) |
| 01/30/1997 | WO1997003202A1 In vivo assays for modulators of sterol biosynthesis |
| 01/30/1997 | WO1997003201A1 Detection and biodegradation of explosives |
| 01/30/1997 | WO1997003200A1 Nucleic acid coding for cmp-n-acetyl-neuraminic acid hydroxylase and its use for the production of modified glycoproteins |
| 01/30/1997 | WO1997003199A1 Herpes simplex virus glycoprotein d variants |
| 01/30/1997 | WO1997003198A2 Nucleotide and amino acid sequence and uses thereof |
| 01/30/1997 | WO1997003197A1 Novel secretion factors for gram-positive microorganisms, genes encoding them and methods of using it |
| 01/30/1997 | WO1997003196A1 CLONING, TISSUE DISTRIBUTION, AND FUNCTIONAL ANALYSIS OF Na+/H+ EXCHANGER ISOFORM, NHE3 |
| 01/30/1997 | WO1997003195A1 Novel factor viii:c polypeptide analogs with altered protease sites |
| 01/30/1997 | WO1997003194A1 Lysine 1689 factor viii:c polypeptide analogs |
| 01/30/1997 | WO1997003193A1 Novel factor viii:c polypeptide analogs with altered metal-binding properties |
| 01/30/1997 | WO1997003192A2 Chromosome 1 gene and gene products related to alzheimer's disease |
| 01/30/1997 | WO1997003191A1 Novel factor viii:c polypeptide analogs comprising factor v domains or subdomains |
| 01/30/1997 | WO1997003190A1 HUMAN GALECTIN-4-LIKE PROTEIN AND cDNA ENCODING THE SAME |
| 01/30/1997 | WO1997003189A1 Rate controller |
| 01/30/1997 | WO1997003188A2 Use of mp52 or mp121 for treating and preventing diseases of the nervous system |
| 01/30/1997 | WO1997003187A2 Marek's disease virus genes and their use in vaccines for protection against marek's disease |
| 01/30/1997 | WO1997003186A2 Method for in vitro proliferation of dentritic cells, composition containing the cells entrapped in a three-dimensional matrix and use for immunization |
| 01/30/1997 | WO1997003185A1 Production of proteins using bacillus incapable of sporulation |
| 01/30/1997 | WO1997003183A1 Pap mutants that exhibit anti-viral and/or anti-fungal activity in plants |
| 01/30/1997 | WO1997003089A2 Method for the preparation of insulin by cleavage of a fusion protein and fusion proteins containing insulin a and b chains |
| 01/30/1997 | WO1997003086A1 Early onset alzheimer's disease gene and gene products |
| 01/30/1997 | WO1997002840A1 Immunovectors for the intracellular and intranuclear transport |
| 01/30/1997 | WO1997002737A1 Cytoplasmic male sterility system producing canola hybrids |
| 01/30/1997 | WO1997002730A2 Enamel matrix related polypeptide |
| 01/30/1997 | WO1996041607A3 Pharmaceutical compositions comprising restrictin p/activin a and use thereof as antagonist of il-6 and/or il-11 |
| 01/30/1997 | WO1996039523A3 Bacterial production of hydrophobic polypeptides |
| 01/30/1997 | WO1996039513A3 Ebnerin cloning of a secreted von ebner's gland protein |
| 01/30/1997 | WO1996039423A3 A method for increasing the electrotransport flux of polypeptides |
| 01/30/1997 | WO1996039195A3 Chemically modified oligonucleotide for site-directed mutagenesis |
| 01/30/1997 | WO1996038555A3 Unc-53 from c. elegans and its uses in testing compounds involved in the control fo cell behaviour and pharmaceutical compositions |
| 01/30/1997 | WO1996035805A3 Tripeptidylpeptidase inhibitors |